https://abt702chemical.com/eff....ect-associated-with-
Following successful genotyping procedures, a total of 2853 patients' genetic information was obtained. Concerning genetic variations, the mutations -516GT and rs3745274 are significant findings. Variation rs2054675 represents a thymine to cytosine mutation, precisely situated at position -1456 in the genome. The primary efficacy and safety results were determined by the occurrence of new stroke and any bleeding events within 90 days. Out of the 285
Like
Comment
Share
